Health innovation networks to help developing countries address neglected diseases.
Gross inequities in disease burden between developed and developing countries are now the subject of intense global attention. Public and private donors have marshaled resources and created organizational structures to accelerate the development of new health products and to procure and distribute drugs and vaccines for the poor. Despite these encouraging efforts directed primarily from and funded by industrialized countries, sufficiency and sustainability remain enormous challenges because of the sheer magnitude of the problem. Here we highlight a complementary and increasingly important means to improve health equity: the growing ability of some developing countries to undertake health innovation.
Morel
Carlos M
CM
Center for Technological Development in Health, Oswaldo Cruz Foundation (FIOCRUZ), Avenida Brasil 4365, Rio de Janeiro, RJ 21040-900, Brazil. morel@fiocruz.br
Acharya
Tara
T
Broun
Denis
D
Dangi
Ajit
A
Elias
Christopher
C
Ganguly
N K
NK
Gardner
Charles A
CA
Gupta
R K
RK
Haycock
Jane
J
Heher
Anthony D
AD
Hotez
Peter J
PJ
Kettler
Hannah E
HE
Keusch
Gerald T
GT
Krattiger
Anatole F
AF
Kreutz
Fernando T
FT
Lall
Sanjaya
S
Lee
Keun
K
Mahoney
Richard
R
Martinez-Palomo
Adolfo
A
Mashelkar
R A
RA
Matlin
Stephen A
SA
Mzimba
Mandi
M
Oehler
Joachim
J
Ridley
Robert G
RG
Senanayake
Pramilla
P
Singer
Peter
P
Yun
Mikyung
M
D035843:Biomedical Research / Q000191:economics; D001709:Biotechnology; D003695:Delivery of Health Care / Q000458:organization & administration; D019049:Developed Countries; D003906:Developing Countries; D004059:Diffusion of Innovation; D004345:Drug Industry; D006291:Health Policy; D006801:Humans; D007391:International Cooperation; D010330:Patents as Topic; D017149:Private Sector; D017150:Public Sector; D011643:Publishing; D018581:Technology Transfer